Cannabis and schizophrenia: A complex relationship
Current Psychiatry December 1, 2023 Joseph M Maes
For some who are predisposed to psychosis, cannabis
Current Psychiatry
4 papers in the library · 4 citations · publishing 2021-2023
Papers
More on psilocybin
Current Psychiatry February 1, 2023 Aryan Sarparast
I would like to remark on “Psychedelics for treating psychiatric disorders: Are they safe?” (Current Psychiatry, December 2022, p. 14-22, doi:10.12788/ cp.0309), specifically “psilocybin use has been decriminalized … and some states (such as Oregon) have legalized it for therapeutic use.
Psychedelics for treating psychiatric disorders: Are they safe?
Current Psychiatry December 1, 2022 Madonna Thakur 3 citations
SAM FALCONERP sychedelics are a class of substances known to produce alterations in consciousness and perception.In the last 2 decades, psychedelic research has garnered increasing attention from scientists, therapists, entrepreneurs, and the public.While many of these compounds remain illegal in the United States and in many parts of the world (Box, 1 page 16), a recent resurrection of...
The rebirth of psychedelic psychiatry
Current Psychiatry 2021 Brian Holoyda 1 citation
M r.P, age 65, has a history of major depressive disorder (MDD), gen- eralized anxiety disorder, and social phobia.Mr. P's personality is high in neuroticism and he has often responded to new situations with feelings of impending doom.For him, fear, anxious rumination, helplessness, and catastrophizing are familiar mental processes.When he was in his 30s, Mr. P had a severe major depressive...